- Home
- VRNA vs CNK Comparison
VRNA vs CNK Comparison
Compare VRNA & CNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRNA
- CNK
- Stock Information
- Founded
- VRNA 2005
- CNK 1984
- Country
- VRNA United Kingdom
- CNK United States
- Employees
- VRNA N/A
- CNK N/A
- Industry
- VRNA Biotechnology: Pharmaceutical Preparations
- CNK Movies/Entertainment
- Sector
- VRNA Health Care
- CNK Consumer Discretionary
- Exchange
- VRNA Nasdaq
- CNK Nasdaq
- Market Cap
- VRNA 3.4B
- CNK 3.8B
- IPO Year
- VRNA 2017
- CNK 2007
- Fundamental
- Price
- VRNA $51.89
- CNK $28.68
- Analyst Decision
- VRNA Strong Buy
- CNK Buy
- Analyst Count
- VRNA 7
- CNK 12
- Target Price
- VRNA $50.57
- CNK $30.92
- AVG Volume (30 Days)
- VRNA 1.4M
- CNK 1.9M
- Earning Date
- VRNA 02-27-2025
- CNK 02-14-2025
- Dividend Yield
- VRNA N/A
- CNK N/A
- EPS Growth
- VRNA N/A
- CNK 99.28
- EPS
- VRNA N/A
- CNK 1.64
- Revenue
- VRNA $5,624,000.00
- CNK $2,874,100,000.00
- Revenue This Year
- VRNA N/A
- CNK N/A
- Revenue Next Year
- VRNA $550.30
- CNK $11.03
- P/E Ratio
- VRNA N/A
- CNK $17.44
- Revenue Growth
- VRNA 1127.95
- CNK N/A
- 52 Week Low
- VRNA $11.39
- CNK $13.45
- 52 Week High
- VRNA $55.42
- CNK $36.28
- Technical
- Relative Strength Index (RSI)
- VRNA 64.25
- CNK 27.02
- Support Level
- VRNA $43.44
- CNK $28.53
- Resistance Level
- VRNA $55.42
- CNK $30.67
- Average True Range (ATR)
- VRNA 3.32
- CNK 0.81
- MACD
- VRNA 0.40
- CNK -0.20
- Stochastic Oscillator
- VRNA 70.52
- CNK 4.80
About VRNA Verona Pharma plc
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.
About CNK Cinemark Holdings Inc Cinemark Holdings Inc.
Cinemark Holdings Inc is geographically diverse operators in the motion picture exhibition industry in the United States. The company operates in around 518 theatres and 5,847 screens in the United States and Latin America. The company generates revenue from filmed entertainment box office receipts and concession sales, with additional revenue from screen advertising, screen rental and other revenue streams, such as transactional fees, vendor marketing promotions, studio trailer placements, meeting rentals and electronic video games located in some of the theatres. Majority of Cinemark's theaters are located in midsize cities or suburbs of large cities.